Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Human monoclonal antibodies to programmed death ligand 1 (PD-L1)

Human monoclonal antibodies to programmed death ligand 1 (PD-L1)

US Patent 9102725 · Granted Aug 11, 2015

Estimated economic value: $158,753,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Engineered CD25 polypeptides and uses thereof2025
Antibodies binding to ILT42025
Antibodies binding to ILT42025
Polynucleotides encoding engineered imine reductases2025
Tumor necrosis factor-like ligand 1A specific antibodies and compositions and us2025
Anti-interleukin-23 P19 antibodies and methods of use thereof2025
Antibodies against TIM3 and uses thereof2025
Antibodies against TIM3 and uses thereof2025
Biocatalysts and methods for hydroxylation of chemical compounds2025
Biocatalysts for the preparation of hydroxy substituted carbamates2025
Combination of TIM-4 antagonist and PD-1 antagonist and methods of use2025
CD25 antibodies2025